Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Very early researchActive Not RecruitingNCT05041153What this trial is testingPembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal AdenocarcinomaWho this might be right forAdvanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage III Gastric Cancer AJCC v8+30 more M.D. Anderson Cancer Center 15
Early research (Phase 1)WithdrawnNCT05296005What this trial is testingNeoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric CancersWho this might be right forClinical Stage I Gastric Cancer AJCC v8Clinical Stage II Gastric Cancer AJCC v8Clinical Stage IIA Gastric Cancer AJCC v8+22 more Ohio State University Comprehensive Cancer Center
Not applicableStudy completedNCT02489422What this trial is testingPrograms To Support You During ChemotherapyWho this might be right forDepressionFatigueStage IIA Colorectal Cancer+18 more Wake Forest University Health Sciences 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT03368963What this trial is testingTAS102 in Combination With NAL-IRI in Advanced GI CancersWho this might be right forColorectal AdenocarcinomaGastric AdenocarcinomaMetastatic Pancreatic Adenocarcinoma+11 more Emory University 64
Early research (Phase 1)Looking for participantsNCT04329494What this trial is testingPIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerWho this might be right forClinical Stage IV Gastric Cancer AJCC v8Clinical Stage IVA Gastric Cancer AJCC v8Clinical Stage IVB Gastric Cancer AJCC v8+24 more City of Hope Medical Center 49
Testing effectiveness (Phase 2)Study completedNCT03918499What this trial is testingIRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction CancerWho this might be right forClinical Stage IV Gastric Cancer AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Gastric Cancer AJCC v8+15 more City of Hope Medical Center 9
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507916What this trial is testingDynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forctDNAGastric CancerGastroesophageal Junction (GEJ) Adenocarcinoma+1 more Fudan University 32
Not applicableStudy completedNCT03154190What this trial is testingHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerWho this might be right forAcute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more Stanford University 128
Early research (Phase 1)Ended earlyNCT02757391What this trial is testingCD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsWho this might be right forColorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Very early researchStudy completedNCT03395847What this trial is testingPembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal AdenocarcinomaWho this might be right forAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8+22 more M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05836584What this trial is testingTesting Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) CancerWho this might be right forClinical Stage I Gastric Cancer AJCC v8Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Gastric Cancer AJCC v8+7 more National Cancer Institute (NCI) 2
Not applicableNot Yet RecruitingNCT07565857What this trial is testingSignatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal CancerWho this might be right forGastric-Esophageal Cancer Natera, Inc. 1,000
Large-scale testing (Phase 3)Study completedNCT00016380What this trial is testingOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenWho this might be right forCancer NCIC Clinical Trials Group 211
Early research (Phase 1)Active Not RecruitingNCT04523818What this trial is testingShort-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric AdenocarcinomaWho this might be right forClinical Stage I Gastric Cancer AJCC v8Clinical Stage IIA Gastric Cancer AJCC v8Clinical Stage III Gastric Cancer AJCC v8+13 more M.D. Anderson Cancer Center 25
Not applicableLooking for participantsNCT04221893What this trial is testingRadiation Therapy for the Treatment of Metastatic Gastrointestinal CancersWho this might be right forStage IV Esophageal AdenocarcinomaStage IV Esophageal Squamous Cell CarcinomaStage IV Gastric Cancer+41 more University of California, San Francisco 28
Not applicableStudy completedNCT04501913What this trial is testingRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesWho this might be right forClinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage 0 Gastric Cancer AJCC v8+169 more City of Hope Medical Center 22
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15